Centers for Disease Control and Prevention (CDC) published a
Signs report that identified an
alarming trend of antibiotic-resistant genes in “nightmare
bacteria” across the United States, on April 03.
CDC warned that nationwide testing - conducted in 2017, uncovered
221 instances of unique resistance genes in “nightmare bacteria.”
According to Fortune,
of all the germ samples submitted to the CDC for lab testing, one
in four had antibiotic-resistant gene characteristics.
America losing the war against antibiotic-resistant
some time, the CDC has warned Americans about the deadly,
drug-resistant ‘superbugs,’ otherwise now called “nightmare
bacteria,” which seems officials have upgraded the term to a much
more dangerous name — reflecting the severity of
bacteria” kills more than 23,000 Americans each year, and the
report states about 11 percent of Americans who were screened had
“no symptoms” before the bacteria aggressively spread.
antibiotic resistance (AR) threats vary nationwide, AR has been
found in every state. And unusual resistance germs, which are
resistant to all or most antibiotics tested and are uncommon or
carry special resistance genes, are constantly developing and
spreading,” the CDC said in a report.
bacteria can spread like wildfire
we found nightmare bacteria in your backyard,” said Dr. Anne
Schuchat, Acting Principal Deputy Director of CDC.
verge on untreatable infections” where the only option may be
supportive care — fluids and sometimes machines to maintain life
to give the patient a chance to recover, Schuchat said.
states about 2 million Americans get infections from
antibiotic-resistant bacteria each year, and around 23,000 people
die from the deadly infections.
Jay Butler, the chief medical officer for the state of Alaska and
past president of the Association of State and Territorial Health
Officials, said, “even in remote areas” the antibiotic-resistant
bacteria threat is real, because those who are infected can
unknowingly transport the deadly bacteria.
identification of the new or rare threats is the critical first
step in CDC’s containment strategy to stop the spread of
antibiotic resistance. When a germ with significant resistance
is detected, facilities can quickly isolate patients and begin
aggressive infection control and screening actions to discover,
reduce, and stop transmission to others,” the CDC said.
can the Federal Government do?
resistance and sounding the alarm when threats emerge. CDC
develops and provides new lab tests so health departments can
quickly identify new threats.
identification through CDC’s new AR Lab Network in all 50
states, 5 large cities, and Puerto Rico, including 7 regional
labs and a national tuberculosis lab for specialty testing.
prevention experts and programs in every state, and providing
data and recommendations for local prevention and response.
innovative infection control and prevention strategies with
health care and academic partners.
and Local Health Departments and Labs must can:
sure all health care facilities know what state and local lab
support is available and what isolates (pure samples of a
germ) to send for testing. Develop a plan to respond rapidly
to unusual genes and germs when they first appear.
the quality and consistency of infection control in health
care facilities across the state, especially in facilities
with high-risk patients and long stays. Help improve
with affected health care facilities, the new AR Lab Network
regional lab, and CDC for every case of unusual resistance.
Investigations should include onsite infection control
assessments to find spread. Consider colonization screenings.
Continue until spread is controlled.
timely lab results and recommendations to affected health care
facilities and providers. If the patient came from or was
transferred to another facility, alert that facility.
efforts detailed in the Vital Signs report were made possible
through new congressional funding in 2016 to combat antibiotic
resistance,” Dr. Auwaerter said. “We urge Congress to sustain
and to grow that investment so that further progress will
prepare us to meet the future challenges of antibiotic
resistance from a position of strength.”
drugs are beneficial and have been around for decades. Here is the
issue, antibiotic-resistant genes in bacteria are getting used to
the drugs. It is a problem the CDC and the federal
government have known for a while, but it is an issue that is more
widespread than previously thought.
Out The Rise of Resistance: